OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
250030.KN56

Jincostech Co Ltd

Personal ProductsVerified

Jincostech maintains a capital structure with a debt-to-equity ratio of 1.29, indicating a moderate reliance on debt financing. The company's liquidity position is characterized by a current ratio of 0.75, suggesting potential short-term liquidity constraints. Free cash flow of 7,079,154,310 KRW supports operational flexibility, but net cash is negative after subtracting total debt, signaling a key liquidity risk. Profitability metrics show a return on equity (ROE) of 32.01% and a return on assets (ROA) of 11.56%, both exceeding typical thresholds for the Personal Products industry. These figures indicate strong asset utilization and equity generation, aligning with the company's focus on high-margin functional cosmetics. The company's revenue is concentrated in its core segments, with no disclosed geographic diversification. This lack of geographic segmentation increases exposure to regional economic shifts and regulatory changes in South Korea. Growth trajectory is supported by a strong operating cash flow of 5,311,100,850 KRW and a free cash flow of 7,079,154,310 KRW. However, capital expenditures are negative at -458,230,030 KRW, suggesting a focus on cost optimization rather than expansion. Risk factors include a medium liquidity risk and a low dilution risk. The company's net cash position is negative after subtracting total debt, and no dilution adjustments are applied in the valuation, indicating a stable capital structure. Recent events include the latest financial filing, which provides updated revenue and profitability figures. No recent transcripts or significant regulatory filings are disclosed, limiting insight into near-term strategic shifts.

30-day price · 250030.KN+2400.00 (+11.0%)
Low$16240.00High$25900.00Close$24300.00As of11 May, 00:00 UTC
Profile
CompanyJincostech Co Ltd
Ticker250030.KN
SectorConsumer Non-Cyclicals
BusinessPersonal & Household Products & Services
Industry groupPersonal & Household Products & Services
IndustryPersonal Products
AI analysis

Business. Jincostech Co Ltd is a Korea-based company engaged in the manufacture and sale of functional cosmetics, including hydrogel eye patches and sun creams, as well as beauty equipment.

Classification. Jincostech is classified under the Personal Products industry within the Personal & Household Products & Services business sector, with a confidence level of 0.92.

Jincostech maintains a capital structure with a debt-to-equity ratio of 1.29, indicating a moderate reliance on debt financing. The company's liquidity position is characterized by a current ratio of 0.75, suggesting potential short-term liquidity constraints. Free cash flow of 7,079,154,310 KRW supports operational flexibility, but net cash is negative after subtracting total debt, signaling a key liquidity risk. Profitability metrics show a return on equity (ROE) of 32.01% and a return on assets (ROA) of 11.56%, both exceeding typical thresholds for the Personal Products industry. These figures indicate strong asset utilization and equity generation, aligning with the company's focus on high-margin functional cosmetics. The company's revenue is concentrated in its core segments, with no disclosed geographic diversification. This lack of geographic segmentation increases exposure to regional economic shifts and regulatory changes in South Korea. Growth trajectory is supported by a strong operating cash flow of 5,311,100,850 KRW and a free cash flow of 7,079,154,310 KRW. However, capital expenditures are negative at -458,230,030 KRW, suggesting a focus on cost optimization rather than expansion. Risk factors include a medium liquidity risk and a low dilution risk. The company's net cash position is negative after subtracting total debt, and no dilution adjustments are applied in the valuation, indicating a stable capital structure. Recent events include the latest financial filing, which provides updated revenue and profitability figures. No recent transcripts or significant regulatory filings are disclosed, limiting insight into near-term strategic shifts.
Key takeaways
  • Jincostech demonstrates strong profitability with ROE of 32.01% and ROA of 11.56%.
  • The company's liquidity position is constrained, with a current ratio of 0.75 and negative net cash after debt.
  • Revenue is concentrated in core segments, with no geographic diversification disclosed.
  • Capital expenditures are negative, indicating a focus on cost control rather than expansion.
  • The company maintains a low dilution risk with no adjustments applied in the valuation.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyKRW
Revenue$48.65B
Gross profit$11.79B
Operating income$4.85B
Net income$6.02B
R&D
SG&A
D&A
SBC
Operating cash flow$5.31B
CapEx-$458.2M
Free cash flow$7.08B
Total assets$52.03B
Total liabilities$33.24B
Total equity$18.80B
Cash & equivalents$6.49B
Long-term debt$24.18B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$48.65B$4.85B$6.02B$7.08B
FY-1$29.84B$1.15B-$41.2M$802.7M
FY-2$19.52B-$2.61B-$3.47B-$2.19B
FY-3$17.60B-$3.19B-$4.66B-$4.37B
FY-4$14.89B-$2.77B-$381.8M-$3.06B
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$52.03B$18.80B$6.49B
FY-1$33.26B$2.37B$3.27B
FY-2$32.00B$2.41B$2.56B
FY-3$32.92B$5.88B$2.50B
FY-4$35.40B$10.53B$3.88B
PeriodOCFCapExFCFSBC
FY0$5.31B-$458.2M$7.08B
FY-1$2.21B-$539.2M$802.7M
FY-2-$1.34B-$194.9M-$2.19B
FY-3-$3.18B-$1.15B-$4.37B
FY-4-$715.5M-$3.74B-$3.06B
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$10.30B-$145.0M$306.5M$532.8M
FQ-1$15.15B$2.41B$2.08B$2.35B
FQ-2$12.31B$1.24B$2.57B$2.87B
FQ-3$10.88B$1.34B$1.06B$1.33B
FQ-4$7.72B$491.8M$472.1M$798.6M
FQ-5$7.29B$105.1M-$192.5M$75.7M
FQ-6$7.67B$407.2M-$213.3M-$183.5M
FQ-7$7.17B$145.7M-$107.5M$111.9M
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0$52.03B$18.80B$6.49B
FQ-1$40.64B$8.08B$5.14B
FQ-2$38.33B$6.00B$3.63B
FQ-3$37.30B$3.43B$4.83B
FQ-4$33.26B$2.37B$3.27B
FQ-5$31.53B$1.89B$2.45B
FQ-6$32.84B$2.09B$2.77B
FQ-7$33.33B$2.30B$2.09B
PeriodOCFCapExFCFSBC
FQ0$5.31B-$458.2M$532.8M
FQ-1$2.73B-$271.7M$2.35B
FQ-2$964.5M-$158.0M$2.87B
FQ-3$1.74B-$77.2M$1.33B
FQ-4$2.21B-$539.2M$798.6M
FQ-5$1.21B-$515.3M$75.7M
FQ-6$1.33B-$437.2M-$183.5M
FQ-7-$193.4M-$119.1M$111.9M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$18.80B
Net cash-$17.69B
Current ratio0.8
Debt/Equity1.3
ROA11.6%
ROE32.0%
Cash conversion88.0%
CapEx/Revenue-0.9%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Personal Products · cohort 225 companies
Metric250030.KNActivity
Op margin10.0%16.2% medp25 16.2% · p75 16.2%bottom quartile
Net margin12.4%10.5% medp25 10.5% · p75 10.5%top quartile
Gross margin24.2%60.1% medp25 60.1% · p75 60.1%bottom quartile
R&D / revenue1.8% medp25 1.8% · p75 1.8%
CapEx / revenue-0.9%-2.3% medp25 -4.4% · p75 -1.1%top quartile
Debt / equity129.0%12724.1% medp25 12724.1% · p75 12724.1%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-12 00:45 UTC#1cbd1cce
Source: analysis-pipeline (hybrid)Generated: 2026-05-12 00:47 UTCJob: 3c143efe